<DOC>
	<DOCNO>NCT02143531</DOCNO>
	<brief_summary>This study aim prove dose 1 mg Haloperidol possess high success rate control establish postoperative nausea vomiting ( PONV ) first 24 hour follow administration similar standard care ondansetron 4 mg .</brief_summary>
	<brief_title>Intravenous Haloperidol Versus Ondansetron Treatment Established Post-operative Nausea Vomiting</brief_title>
	<detailed_description>Patients undergo surgery general anesthesia may experience several complication postoperative period . Nausea vomit common complication . Several medication use prevention specific complication , treatment remain cost-efficient . Haloperidol anti-psychotic , low dos , prevent occurrence nausea vomit . Its usefulness prophylaxis demonstrate several study . However , use treat establish postoperative nausea vomiting ( PONV ) properly study . In prospective randomized clinical trial involve adult patient undergo elective surgery general anesthesia , investigator enroll 120 patient , compare effect dose 1 mg Haloperidol versus Ondansetron 4 mg document vary degree success treat nausea vomit well possible side effect . Investigators expect observe Haloperidol effective treatment Ondansetron .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>Patients age 1880 ASA class I , II , III undergo elective surgery general anesthesia Patients history arrhythmia , QTc prolongation allergy study drug exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>